Loading clinical trials...
Loading clinical trials...
Peds II (Pediatric Eplerenone Development Study II)--An Open Label, Long-Term Study To Evaluate The Safety Of Eplerenone In The Treatment Of Hypertension In Children
Conditions
Interventions
Eplerenone
Locations
21
United States
Pfizer Investigational Site
Los Angeles, California, United States
Pfizer Investigational Site
Park Ridge, Illinois, United States
Pfizer Investigational Site
Durham, North Carolina, United States
Pfizer Investigational Site
Columbus, Ohio, United States
Pfizer Investigational Site
Columbus, Ohio, United States
Pfizer Investigational Site
Houston, Texas, United States
Start Date
October 1, 2004
Completion Date
June 1, 2006
Last Updated
December 22, 2020
NCT06647511
NCT07439939
NCT05746039
NCT07218029
NCT07098065
NCT06741436
Lead Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions